Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Correlation between salivary secretion and salivary AQP5 levels in health and disease.

Wang D, Iwata F, Muraguchi M, Ooga K, Ohmoto Y, Takai M, Mori T, Ishikawa Y.

J Med Invest. 2009;56 Suppl:350-3.

2.

Identification of aquaporin-5 and lipid rafts in human resting saliva and their release into cevimeline-stimulated saliva.

Pan Y, Iwata F, Wang D, Muraguchi M, Ooga K, Ohmoto Y, Takai M, Cho G, Kang J, Shono M, Li XJ, Okamura K, Mori T, Ishikawa Y.

Biochim Biophys Acta. 2009 Jan 1;1790(1):49-56. doi: 10.1016/j.bbagen.2008.08.009. Epub 2008 Sep 10.

PMID:
18822351
3.
4.
5.

Comparison of the effects of pilocarpine and cevimeline on salivary flow.

Braga MA, Tarzia O, Bergamaschi CC, Santos FA, Andrade ED, Groppo FC.

Int J Dent Hyg. 2009 May;7(2):126-30. doi: 10.1111/j.1601-5037.2008.00326.x.

PMID:
19416095
6.

Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjögren's syndrome patients.

Steinfeld S, Cogan E, King LS, Agre P, Kiss R, Delporte C.

Lab Invest. 2001 Feb;81(2):143-8.

PMID:
11232635
7.

Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy.

Soyfoo MS, De Vriese C, Debaix H, Martin-Martinez MD, Mathieu C, Devuyst O, Steinfeld SD, Delporte C.

Arthritis Rheum. 2007 Aug;56(8):2566-74. Erratum in: Arthritis Rheum. 2007 Sep;56(9):3172.

8.

Effect of cevimeline on radiation-induced salivary gland dysfunction and AQP5 in submandibular gland in mice.

Takakura K, Takaki S, Takeda I, Hanaue N, Kizu Y, Tonogi M, Yamane GY.

Bull Tokyo Dent Coll. 2007 May;48(2):47-56.

9.

Degradation of submandibular gland AQP5 by parasympathetic denervation of chorda tympani and its recovery by cevimeline, an M3 muscarinic receptor agonist.

Li X, Azlina A, Karabasil MR, Purwanti N, Hasegawa T, Yao C, Akamatsu T, Hosoi K.

Am J Physiol Gastrointest Liver Physiol. 2008 Jul;295(1):G112-G123. doi: 10.1152/ajpgi.00359.2007. Epub 2008 May 1.

10.

Identification of AQP5 in lipid rafts and its translocation to apical membranes by activation of M3 mAChRs in interlobular ducts of rat parotid gland.

Ishikawa Y, Yuan Z, Inoue N, Skowronski MT, Nakae Y, Shono M, Cho G, Yasui M, Agre P, Nielsen S.

Am J Physiol Cell Physiol. 2005 Nov;289(5):C1303-11. Epub 2005 Aug 17.

11.

Autoantibodies against muscarinic type 3 receptor in Sjögren's syndrome inhibit aquaporin 5 trafficking.

Lee BH, Gauna AE, Perez G, Park YJ, Pauley KM, Kawai T, Cha S.

PLoS One. 2013;8(1):e53113. doi: 10.1371/journal.pone.0053113. Epub 2013 Jan 30.

12.

Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients.

Yoshimura S, Nakamura H, Horai Y, Nakajima H, Shiraishi H, Hayashi T, Takahashi T, Kawakami A.

Mod Rheumatol. 2016;26(3):384-90. doi: 10.3109/14397595.2015.1083146. Epub 2016 Mar 29.

PMID:
26375433
13.

Dendrobium candidum extract increases the expression of aquaporin-5 in labial glands from patients with Sjögren's syndrome.

Xiao L, Ng TB, Feng YB, Yao T, Wong JH, Yao RM, Li L, Mo FZ, Xiao Y, Shaw PC, Li ZM, Sze SC, Zhang KY.

Phytomedicine. 2011 Jan 15;18(2-3):194-8. doi: 10.1016/j.phymed.2010.05.002. Epub 2010 Jul 23.

PMID:
20655712
14.

Effect of cevimeline on salivary components in patients with Sjögren syndrome.

Suzuki K, Matsumoto M, Nakashima M, Takada K, Nakanishi T, Okada M, Ohsuzu F.

Pharmacology. 2005 May;74(2):100-5. Epub 2005 Feb 18.

PMID:
15722648
16.

E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.

Matsui-Inohara H, Uematsu H, Narita T, Satoh K, Yonezawa H, Kuroda K, Ito T, Yoneda S, Kawarai T, Sugiya H, Watanabe H, Senpuku H.

Exp Biol Med (Maywood). 2009 Dec;234(12):1525-36. doi: 10.3181/0905-RM-173.

PMID:
19934373
17.

Use of muscarinic agonists in the treatment of Sjögren's syndrome.

Fox RI, Konttinen Y, Fisher A.

Clin Immunol. 2001 Dec;101(3):249-63. Review.

PMID:
11726216
18.

New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.

Tsuboi H, Matsumoto I, Wakamatsu E, Nakamura Y, Iizuka M, Hayashi T, Goto D, Ito S, Sumida T.

Clin Exp Immunol. 2010 Oct;162(1):53-61. doi: 10.1111/j.1365-2249.2010.04188.x. Epub 2010 Aug 20.

19.

Salivary acinar cells from aquaporin 5-deficient mice have decreased membrane water permeability and altered cell volume regulation.

Krane CM, Melvin JE, Nguyen HV, Richardson L, Towne JE, Doetschman T, Menon AG.

J Biol Chem. 2001 Jun 29;276(26):23413-20. Epub 2001 Apr 4.

20.

s-IgA and cytokine levels in whole saliva of Sjögren's syndrome patients before and after oral pilocarpine hydrochloride administration: a pilot study.

Rhodus N, Dahmer L, Lindemann K, Rudney J, Mathur A, Bereuter J.

Clin Oral Investig. 1998 Dec;2(4):191-6.

PMID:
10388393

Supplemental Content

Support Center